YKL-40 is overexpressed in cancers and tumor-associated macrophages, and its serum levels are elevated in patients with metastatic cancers and in various chronic inflammatory diseases, implicating pathological role of YKL-40 in cancer progression, metastasis, and inflammation [1,3,4,5,6]. The gene discussed is CHI3L1; the disease is cancer.